Found: 144
Select item for more details and to access through your institution.
Clinical impact of mutated JAK2 allele burden reduction in polycythemia vera and essential thrombocythemia.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 8, p. 1550, doi. 10.1002/ajh.27400
- By:
- Publication type:
- Article
Risk models in myelofibrosis—the past, present, and future.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 4, p. 519, doi. 10.1002/ajh.27270
- By:
- Publication type:
- Article
The prognostic contribution of CBL, NRAS, KRAS, RUNX1, and TP53 mutations to mutation‐enhanced international prognostic score systems (MIPSS70/plus/plus v2.0) for primary myelofibrosis.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 1, p. 68, doi. 10.1002/ajh.27136
- By:
- Publication type:
- Article
A globally applicable "triple A" risk model for essential thrombocythemia based on Age, Absolute neutrophil count, and Absolute lymphocyte count.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 12, p. 1829, doi. 10.1002/ajh.27079
- By:
- Publication type:
- Article
Concomitant myeloproliferative neoplasm with eosinophilia, B and T cell lymphoblastic lymphoma/leukemia and mast cell proliferation driven by ZMYM2::FGFR1 rearrangement.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 12, p. 1959, doi. 10.1002/ajh.27026
- By:
- Publication type:
- Article
JAK2 inhibitor treatment of anemia in myelofibrosis.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 7, p. 995, doi. 10.1002/ajh.26934
- By:
- Publication type:
- Article
Diagnostic and therapeutic challenges in mast cell sarcoma.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 529, doi. 10.1002/ajh.26804
- By:
- Publication type:
- Article
The international consensus classification of myeloid neoplasms and acute Leukemias: myeloproliferative neoplasms.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 1, p. 166, doi. 10.1002/ajh.26751
- By:
- Publication type:
- Article
SF3B1 mutations in primary and secondary myelofibrosis: Clinical, molecular and prognostic correlates.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 9, p. E347, doi. 10.1002/ajh.26648
- By:
- Publication type:
- Article
Integration of multiparameter flow cytometry score improves prognostic stratification provided by standard models in primary myelofibrosis.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. 846, doi. 10.1002/ajh.26548
- By:
- Publication type:
- Article
Deciphering the individual contribution of absolute neutrophil and monocyte counts to thrombosis risk in polycythemia vera and essential thrombocythemia.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 2, p. E35, doi. 10.1002/ajh.26423
- By:
- Publication type:
- Article
Cerebral venous thrombosis and myeloproliferative neoplasms: A three‐center study of 74 consecutive cases.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 12, p. 1580, doi. 10.1002/ajh.26336
- By:
- Publication type:
- Article
Clinical and molecular predictors of fibrotic progression in essential thrombocythemia: A multicenter study involving 1607 patients.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 11, p. 1472, doi. 10.1002/ajh.26332
- By:
- Publication type:
- Article
Impaired response to first SARS‐CoV‐2 dose vaccination in myeloproliferative neoplasm patients receiving ruxolitinib.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 11, p. E408, doi. 10.1002/ajh.26305
- By:
- Publication type:
- Article
Venetoclax with azacitidine or decitabine in blast‐phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 7, p. 781, doi. 10.1002/ajh.26186
- By:
- Publication type:
- Article
Lenalidomide: A double‐edged sword for concomitant multiple myeloma and post‐essential thrombocythemia myelofibrosis.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 6, p. 749, doi. 10.1002/ajh.26153
- By:
- Publication type:
- Article
Extreme thrombocytosis in low‐risk essential thrombocythemia: Retrospective review of vascular events and treatment strategies.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 6, p. E182, doi. 10.1002/ajh.26137
- By:
- Publication type:
- Article
A case of aleukemic mast cell leukemia with an underlying myeloproliferative neoplasm: Morphological and molecular characteristics of a highly aggressive disease.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1622, doi. 10.1002/ajh.25806
- By:
- Publication type:
- Article
Fedratinib in patients with myelofibrosis previously treated with ruxolitinib: An updated analysis of the JAKARTA2 study using stringent criteria for ruxolitinib failure.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 6, p. 594, doi. 10.1002/ajh.25777
- By:
- Publication type:
- Article
Phenotypic correlates and prognostic outcomes of TET2 mutations in myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: A comprehensive study of 504 adult patients.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 4, p. E86, doi. 10.1002/ajh.25721
- By:
- Publication type:
- Article
Characteristics and clinical correlates of NFE2 mutations in chronic Myeloproliferative neoplasms.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 1, p. E23, doi. 10.1002/ajh.25668
- By:
- Publication type:
- Article
Myelodysplasia as assessed by multiparameter flow cytometry refines prognostic stratification provided by genotypic risk in systemic mastocytosis.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 8, p. 845, doi. 10.1002/ajh.25506
- By:
- Publication type:
- Article
The JAK2 46/1 (GGCC) MPN‐predisposing haplotype: A risky haplotype, after all.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 3, p. 283, doi. 10.1002/ajh.25367
- By:
- Publication type:
- Article
A case of disseminated blastic plasmocytoid dendritic cell neoplasm.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 11, p. 1433, doi. 10.1002/ajh.25109
- By:
- Publication type:
- Article
<italic>JAK2</italic> exon 12 mutated polycythemia vera: Mayo‐Careggi MPN Alliance study of 33 consecutive cases and comparison with <italic>JAK2</italic>V617F mutated disease.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 4, p. E93, doi. 10.1002/ajh.25017
- By:
- Publication type:
- Article
Driver mutations and prognosis in primary myelofibrosis: Mayo‐Careggi MPN alliance study of 1,095 patients.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 3, p. 348, doi. 10.1002/ajh.24978
- By:
- Publication type:
- Article
Gender and survival in essential thrombocythemia: A two-center study of 1,494 patients.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 11, p. 1193, doi. 10.1002/ajh.24882
- By:
- Publication type:
- Article
European LeukemiaNet study on the reproducibility of bone marrow features in masked polycythemia vera and differentiation from essential thrombocythemia.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 10, p. 1062, doi. 10.1002/ajh.24837
- By:
- Publication type:
- Article
Diagnostic impact of the 2016 revised who criteria for polycythemia vera.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 5, p. 417, doi. 10.1002/ajh.24684
- By:
- Publication type:
- Article
The effect of arterial hypertension on thrombosis in low-risk polycythemia vera.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 1, p. E5, doi. 10.1002/ajh.24583
- By:
- Publication type:
- Article
The prognostic impact of bone marrow fibrosis in primary myelofibrosis.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 10, p. E454, doi. 10.1002/ajh.24482
- By:
- Publication type:
- Article
Improving prognostic tools in systemic mastocytosis: Insights from mutations.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 9, p. 867, doi. 10.1002/ajh.24472
- By:
- Publication type:
- Article
Myeloproliferative neoplasms: Morphology and clinical practice.
- Published in:
- American Journal of Hematology, 2016, v. 91, p. 430, doi. 10.1002/ajh.24288
- By:
- Publication type:
- Article
Myeloproliferative neoplasms: Morphology and clinical practice.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 4, p. 430, doi. 10.1002/ajh.24288
- By:
- Publication type:
- Article
Patterns of presentation and thrombosis outcome in patients with polycythemia vera strictly defined by WHO-criteria and stratified by calendar period of diagnosis.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 5, p. 434, doi. 10.1002/ajh.23970
- By:
- Publication type:
- Article
Ruxolitinib-induced reversal of alopecia universalis in a patient with essential thrombocythemia.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 1, p. 82, doi. 10.1002/ajh.23871
- By:
- Publication type:
- Article
Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms An European Leukemia Net study.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 11, p. E200, doi. 10.1002/ajh.23809
- By:
- Publication type:
- Article
Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: A collaborative study of 1027 patients.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 8, p. E121, doi. 10.1002/ajh.23743
- By:
- Publication type:
- Article
Discriminating between essential thrombocythemia and masked polycythemia vera in JAK2 mutated patients.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 6, p. 588, doi. 10.1002/ajh.23694
- By:
- Publication type:
- Article
CALR mutations in myeloproliferative neoplasms: Hidden behind the reticulum.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 5, p. 453, doi. 10.1002/ajh.23678
- By:
- Publication type:
- Article
Complex karyotype in a polycythemia vera patient with a novel SETD1B/GTF2H3 fusion gene.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 4, p. 438, doi. 10.1002/ajh.23659
- By:
- Publication type:
- Article
Masked polycythemia vera diagnosed according to WHO and BCSH classification.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 2, p. 199, doi. 10.1002/ajh.23617
- By:
- Publication type:
- Article
Masked polycythemia Vera (mPV): Results of an international study.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 1, p. 52, doi. 10.1002/ajh.23585
- By:
- Publication type:
- Article
Clinical significance of genetic aberrations in secondary acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 11, p. 1010, doi. 10.1002/ajh.23309
- By:
- Publication type:
- Article
Leukocytosis as an important risk factor for arterial thrombosis in WHO-defined early/prefibrotic myelofibrosis: An international study of 264 patients.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 7, p. 669, doi. 10.1002/ajh.23217
- By:
- Publication type:
- Article
Unraveling the genetic underpinnings of myeloproliferative neoplasms and understanding their effect on disease course and response to therapy: Proceedings from the 6th international post-ASH symposium.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 5, p. 562, doi. 10.1002/ajh.23169
- By:
- Publication type:
- Article
Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 3, p. 245, doi. 10.1002/ajh.22257
- By:
- Publication type:
- Article
Blood tests may predict early primary myelofibrosis in patients presenting with essential thrombocythemia.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 2, p. 203, doi. 10.1002/ajh.22241
- By:
- Publication type:
- Article
Phase I/II study of single-agent bortezomib for the treatment of patients with myelofibrosis. Clinical and biological effects of proteasome inhibition.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 8, p. 616, doi. 10.1002/ajh.21754
- By:
- Publication type:
- Article
Carfilzomib, lenalidomide, and dexamethasone in relapsed refractory multiple myeloma: a prospective real-life experience of the Regional Tuscan Myeloma Network.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1162990
- By:
- Publication type:
- Article